ABCL - AbCellera Biologics Inc. (ABCL) Q1 2024 Earnings Call Transcript
2024-05-07 23:00:08 ET
AbCellera Biologics Inc. (ABCL)
Q1 2024 Earnings Conference Call
May 07, 2024 05:00 PM ET
Company Participants
Tryn Stimart - Chief Legal & Compliance Officer
Carl Hansen - President, Chief Executive Officer
Andrew Booth - Chief Financial Officer
Conference Call Participants
Andrea Tan - Goldman Sachs
Jacqueline Kisa - TD Securities
Scott Schoenhaus - KeyBanc
Stephen Willey - Stifel
Presentation
Operator
Good afternoon and welcome to AbCellera's Q1, 2024 Business Update Conference Call. My name is Harry and I will facilitate the audio portion of today's interactive broadcast. [Operator Instructions].
At this time, I would like to turn the call over to Tryn Stimart, AbCellera's Chief Legal and Compliance Officer. Please go ahead.
Tryn Stimart
Good morning. Good afternoon and good evening to everyone listening around the world. Thank you for joining us for AbCellera's 2024 first quarter earnings call. I'm Tryn Stimart, AbCellera's Chief Legal and Compliance Officer. Joining me on today's call are Dr. Carl Hansen, AbCellera's President and CEO and Andrew Booth, AbCellera's Chief Financial Officer.
During this call, we anticipate making projections and forward-looking statements based on our current expectations and pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995....
AbCellera Biologics Inc. (ABCL) Q1 2024 Earnings Call Transcript